Delivery of Teprotumumab medicinal product
Original notice title
Poland – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – DZP.242.268.2026 - Dostawa produktu leczniczego – Teprotumumab
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Award Criteria
Lot 1
Buyer
Location
WROCŁAW, POL
Website
Buyer profile
Identifier
8981816856
Activity
Health
Lots (1)
LOT-0001
Dostawa produktu leczniczego – Teprotumumab
Dostawa produktu leczniczego – Teprotumumab - 1 ZADANIE
PLN 668.1k
Estimated value
Location
Duration
Category
Award Criteria
Award details
1. Za ofertę najkorzystniejszą zostanie uznana oferta zawierająca najniższą cenę: „Cena” – C
Procurement Details
- Publication date
- 24 Jun 2026
- Languages
- Polish
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 433146-2026
Documents (1)
Similar tenders
Czechia – Specialised chemical products – DNS - chemikálie pro molekulární a buněčnou biologii
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на УМБАЛ "Царица Йоанна-ИСУЛ" ЕАД
Lithuania – Pharmaceutical products – Vaistų ir kitų farmacijos produktų pirkimas
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на ВМА и подчинените й структури
Lithuania-Kaunas: General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications